Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal

19 Oct 2020

Abstract excerpt

The beginning of the 21st century has been marked by three distinct waves of zoonotic coronavirus outbreaks into the human population. The COVID-19 (coronavirus disease 2019) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and emerged as a global threat endangering the livelihoods of millions worldwide. Currently, and despite collaborative efforts, diverse therapeutic strategies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to PARP inhibition in cancer therapy
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33103068
DOI: 10.1016/j.isci.2020.101697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalPMID 33103068Read ↗

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read ↗

Integrative transcriptome analyses empower the anti-COVID-19 drug arsenalSemantic proximity Read ↗

Large Scale Profiling of SARS-CoV-2-Infected Patients Identified Potential Therapeutic Host Targets and Drug Candidates for COVID-19Semantic proximity Read ↗

Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity Read ↗

A Transcriptome Analysis Identifies Potential Preventive and Therapeutic Approaches Towards COVID-19Semantic proximity Read ↗

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSSemantic proximity Read ↗

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read ↗

An In-Silico Analysis of Drugs Potentially Modulating the Cytokine Storm Triggered by SARS-CoV-2 Infection<strong> </strong>Semantic proximity Read ↗

A system biology approach identifies candidate drugs to reduce mortality in severely ill COVID-19 patientsSemantic proximity Read ↗

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposingSemantic proximity Read ↗

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity Read ↗

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.